Sharon Shacham Karyopharm Therapeutics Inc. (KPTI) insider trading activity
Sharon Shacham is Chief Scientific Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 958,131 shares of KPTI, which is worth approximately $804,830. The most recent transaction as insider was on Mar 29, 2022, when has been sold 60,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
958K
0%
3M change
0%
12M change
Total Value Held
$804,830
Sharon Shacham Transaction History
Also insider at
SS
Sharon Shacham
Chief Scientific Officer
Newton, MA